Improved mutants from directed evolution are biased to orthologous substitutions.
We have engineered human epidermal growth factor (EGF) by directed evolution through yeast surface display for significantly enhanced affinity for the EGF receptor (EGFR). Statistical analysis of improved EGF mutants isolated from randomly mutated yeast-displayed libraries indicates that mutations are biased towards substitutions at positions exhibiting significant phylogenetic variation. In particular, mutations in high-affinity EGF mutants are statistically biased towards residues found in orthologous EGF species. This same trend was also observed with other proteins engineered through directed evolution in our laboratory (EGFR, interleukin-2) and in a meta-analysis of reported results for engineered subtilisin. By contrast, reported loss-of-function mutations in EGF were biased towards highly conserved positions. Based on these findings, orthologous mutations were introduced into a yeast-displayed EGF library by a process we term shotgun ortholog scanning mutagenesis (SOSM). EGF mutants with a high frequency of the introduced ortholog mutations were isolated through screening the library for enhanced binding affinity to soluble EGFR ectodomain. These mutants possess a 30-fold increase in binding affinity over wild-type EGF to EGFR-transfected fibroblasts and are among the highest affinity EGF proteins to be engineered to date. Collectively, our findings highlight a general approach for harnessing information present in phylogenetic variability to create useful genetic diversity for directed evolution. Our SOSM method exploits the benefits of library diversity obtained through complementary methods of error-prone PCR and DNA shuffling, while circumventing the need for acquisition of multiple genes for family or synthetic shuffling.
Cochran
Jennifer R
JR
Division of Biological Engineering, Massachusetts Institute of Technology Cambridge, MA 02139, USA.
Kim
Yong-Sung
YS
Lippow
Shaun M
SM
Rao
Balaji
B
Wittrup
K Dane
KD
D001483:Base Sequence; D015374:Biosensing Techniques; D019020:Directed Molecular Evolution; D004815:Epidermal Growth Factor / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D066246:ErbB Receptors / Q000235:genetics / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism; D015723:Gene Library; D006801:Humans; D007376:Interleukin-2 / Q000235:genetics / Q000378:metabolism; D016296:Mutagenesis; D009154:Mutation; D010802:Phylogeny; D011485:Protein Binding; D013381:Subtilisins / Q000235:genetics / Q000378:metabolism; D014162:Transfection / Q000379:methods; D015003:Yeasts / Q000235:genetics
D007376:Interleukin-2; D004815:Epidermal Growth Factor; D066246:ErbB Receptors; D013381:Subtilisins